Inventor

Ronald J. Doll

Inventor

Maplewood, NJ, US

Overview

1984–2017

Patent span

Human necessities

Primary field (CPC A)

Patents· 107 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds43%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%

A61KPreparations for medical, dental or toiletry purposes19%

C07KPeptides2%

C07CAcyclic or carbocyclic compounds1%

F16PSafety devices in general1%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

F16DCouplings for transmitting rotation0%

Y10TTechnical subjects covered by former us classification0%

PatentTitleYear

9,637,493'Substituted pyrrolopyrimidines as HDM2 inhibitors'2017 9,540,377'2,6,7,8 substituted purines as HDM2 inhibitors'2017 8,987,274'Macrocycles that increase p53 activity and the uses thereof'2015 8,962,611'Substituted imidazopyridines as HDM2 inhibitors'2015 8,859,776'Substituted piperidines that increase p53 activity and the uses thereof'2014 8,846,657'Substituted imidazopyridines as HDM2 inhibitors'2014 8,673,924'Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors'2014 8,658,651'Compounds that are ERK inhibitors'2014 8,623,857'N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1'2014 8,546,404'Compounds that are ERK inhibitors'2013 7,884,107'Substituted piperidines that increase P53 activity and the uses thereof'2011 7,807,683'N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors'2010 7,807,672'Compounds that are ERK inhibitors'2010 7,608,643'Compounds for inhibiting KSP kinesin activity'2009 7,557,107'Farnesyl protein transferase inhibitors as antitumor agents'2009 7,514,442'Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors'2009 7,511,049'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2009 7,485,645'17Î²-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'2009 7,470,695'N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors'2008 7,468,372'Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors'2008 7,452,902'Imidazopyridines as cyclin dependent kinase inhibitors'2008 7,432,265'Imidazopyrazines as cyclin dependent kinase inhibitors'2008 7,432,268'17Î²-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'2008 7,342,016'Farnesyl protein transferase inhibitors as antitumor agents'2008 7,309,705'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2007 7,275,995'Adjustable guard for protecting coupling connection between rotating shafts'2007 7,271,174'Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases'2007 7,271,175'17Î²-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'2007 7,186,740'Imidazopyrazines as cyclin dependent kinase inhibitors'2007 7,161,003'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2007 7,151,104'Pyrazolopyridines as cyclin dependent kinase inhibitors'2006 7,138,396'17 Î²-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'2006 7,119,200'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2006 7,084,271'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2006 7,078,525'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2006 7,074,924'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2006 7,067,661'Pyrazolopyrimidines as cyclin dependent kinase inhibitors'2006 7,053,091'17 Î²-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'2006 6,992,080'Imidazopyridines as cyclin dependent kinase inhibitors'2006 6,919,341'Imidazopyrazines as cyclin dependent kinase inhibitors'2005 6,903,102'17Î²-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'2005 6,800,636'Farnesyl protein transferase inhibitors'2004 6,740,661'Farnesyl protein transferase inhibitors'2004 6,689,789'Compounds useful for inhibition of farnesyl protein transferase'2004 6,576,639'Compounds for the inhibition of farnesyl protein transferase'2003 6,492,381'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'2002 6,440,974'Compounds useful for inhibition of farnesyl protein transferase'2002 6,432,959'Inhibitors of farnesyl-protein transferase'2002 6,426,352'Sulfonamide inhibitors of farnesyl-protein transferase'2002 6,410,541'Compounds useful for inhibition of farnesyl protein transferase'2002 6,387,905'Compounds useful for inhibition of farnesyl protein transferase'2002 6,372,747'Farnesyl protein transferase inhibitors'2002 6,365,588'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'2002 6,362,188'Farnesyl protein transferase inhibitors'2002 6,333,333'Methods for treating proliferative diseases'2001 6,300,338'Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases'2001 6,277,854'Tricyclic antitumor farnesyl protein transferase inhibitors'2001 6,241,618'Adjustable rotating shaft guard'2001 6,242,458'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'2001 6,239,140'Compounds useful for inhibition of farnesyl protein transferase'2001 6,228,865'Compounds useful for inhibition of farnesyl protein transferase'2001 6,228,856'Compounds useful for inhibition of farnesyl protein transferase'2001 6,214,828'Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease'2001 6,214,827'Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'2001 6,211,193'Compounds useful for inhibition of farnesyl protein transferase'2001 6,143,758'Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases'2000 6,124,295'Compounds useful for inhibition of farnesyl protein transferase'2000 6,096,757'Method for treating proliferative diseases'2000 6,075,025'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'2000 6,030,982'Compounds useful for inhibition of farnesyl protein transferase'2000 5,994,364'Tricyclic antitumor farnesyl protein transferase inhibitors'1999 5,977,128'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1999 5,965,570'Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase'1999 5,958,940'Tricyclic compounds useful as inhibitors of farnesyl-protein transferase'1999 5,945,429'Compounds useful for inhibition of farnesyl protein transferase'1999 5,945,430'Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase'1999 5,939,416'Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors'1999 5,925,648'Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase'1999 5,925,639'Keto amide derivatives useful as farnesyl protein transferase inhibitors'1999 5,891,872'Tricyclic compounds'1999 5,880,128'Carbonyl piperazinyl and piperidinyl compounds'1999 5,874,442'Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease'1999 5,861,395'Compounds useful for inhibition of farnesyl proteins transferase'1999 5,807,853'Tricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseases'1998 5,807,852'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1998 5,801,175'Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1998 5,728,703'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1998 5,721,236'Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1998 5,719,148'Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases'1998 5,714,609'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1998 5,712,280'Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1998 5,700,806'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1997 5,696,121'Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1997 5,672,611'Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1997 5,661,152'Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases'1997 5,461,057'Hydro-ethano-indeno-pyridines'1995 5,091,431'Phosphodiesterase inhibitors'1992 4,971,972'Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion'1990 4,879,309'Mercapto-acylamino acids as antihypertensives'1989 4,840,772'Antiglaucoma compositions and methods'1989 4,803,206'Antihypertensive acylpyrazines'1989 4,783,444'Antiglaucoma compositions and methods'1988 4,691,049'Process for preparing a specific diastereomer of a monoamino dicarboxylic acid ester'1987 4,584,285'Antihypertensive agents'1986 4,511,569'Tricyclic lactams and derivatives useful in increasing cardiac contractility'1985 4,474,786'Tricyclic lactams and derivatives useful in increasing cardiac contractility'1984 4,431,644'Antihypertensive agents'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–2010Patents assigned to SCHERING CORP (86)· patent assignee history

1984–2004Based in Maplewood, NJ, US· patent location history

1998–2009Patents assigned to PHARMACOPEIA INC (6)· patent assignee history

2001–2007Based in Cedarburg, WI, US· patent location history

2004–2017Based in Convent Station, NJ, US· patent location history

2006–2007Patents assigned to PHARMACOPEIA DRUG DISCOVERY (6)· patent assignee history

2013–2017Patents assigned to MERCK SHARP & DOHME (10)· patent assignee history

2013–2015Patents assigned to DOLL RONALD J (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SCHERING CORP	86	1984–2010
MERCK SHARP & DOHME	10	2013–2017
DOLL RONALD Jself	6	2013–2015
PHARMACOPEIA DRUG DISCOVERY	6	2006–2007
PHARMACOPEIA INC	6	1998–2009

Locations

Location	Patents	Span
Maplewood, New Jersey, US	64	1984–2004
Convent Station, New Jersey, US	41	2004–2017
Cedarburg, WI, US	2	2001–2007